[1]
|
GOLD (2018) Global Initiative for Chronic Obstructive Lung Disease. 1-123.
|
[2]
|
Vogelmeier, C.F., Criner, G.J., Martinez, F.J., et al. (2017) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. American Journal of Respiratory and Critical Care Medicine, 195, 557-582. https://doi.org/10.1164/rccm.201701-0218PP
|
[3]
|
Wedzicha, J.A. and Seemungal, T.A. (2007) COPD Exacerbations: Defining Their Cause and Prevention. The Lancet, 370, 786-796. https://doi.org/10.1016/S0140-6736(07)61382-8
|
[4]
|
Goli, G., Mukka, R. and Sairi, S. (2016) Study of Serum Electrolytes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients. International Journal of Re-search in Medical Sciences, 4, 3324-3327.
https://doi.org/10.1007/s00408-009-9222-y
|
[5]
|
Agusti, A. and Faner, R. (2019) Lung Function Trajectories in Health and Disease. The Lancet Respiratory Medicine, 7, 358-364. https://doi.org/10.1016/S2213-2600(18)30529-0
|
[6]
|
van der Molen, T., Miravitlles, M. and Kocks, J.W. (2013) COPD Management: Role of Symptom Assessment in Routine Clinical Practice. International Journal of Chronic Ob-structive Pulmonary Disease, 8, 461-471.
https://doi.org/10.2147/COPD.S49392
|
[7]
|
Lange, P., Celli, B., Agusti, A., et al. (2015) VestboLung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. The New England Journal of Medicine, 373, 111-122. https://doi.org/10.1056/NEJMoa1411532
|
[8]
|
Celli, B.R., Thomas, N.E. anderson, J.A., et al. (2008) Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study. American Journal of Respiratory and Critical Care Medicine, 178, 332-333. https://doi.org/10.1164/rccm.200712-1869OC
|
[9]
|
Howard, P. (1970) A Long-Term Follow-Up of Respiratory Symptoms and Ventilatory Function in a Group of Working Men. British Journal of Industrial Medicine, 27, 326-333. https://doi.org/10.1136/oem.27.4.326
|
[10]
|
Silverman, E.K. (2007) Exacerbations in Chronic Obstructive Pulmonary Disease: Do They Contribute to Disease Progression? Proceedings of the American Thoracic Society, 4, 586-590. https://doi.org/10.1513/pats.200706-068TH
|
[11]
|
Dransfield, M.T., Kunisaki, K.M., Strand, M.J., et al. (2016) Acute Exacerbations and Lung Function Loss in Smokers with and without COPD. American Journal of Respiratory and Critical Care Medicine, 195, 324-330.
https://doi.org/10.1164/rccm.201605-1014OC
|
[12]
|
Donaldson, G.C., Law, M., Kowlessar, B., et al. (2015) Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 192, 943-950.
https://doi.org/10.1164/rccm.201412-2269OC
|
[13]
|
Burg, M.B. and Ferraris, J.D. (2008) Intracellular Organic Osmolytes: Function and Regulation. Journal of Biological Chemistry, 283, 7309-7313. https://doi.org/10.1074/jbc.R700042200
|
[14]
|
Palmer, L.G. and Schnermann, J. (2015) Integrated Control of Na Transport along the Nephron. Clinical Journal of the American Society of Nephrology, 10, 676-687. https://doi.org/10.2215/CJN.12391213
|
[15]
|
Sterns, R.H., Nigwekar, S.U. and Hix, J.K. (2009) The Treatment of Hyponatremia. Seminars in Nephrology, 29, 282-299. https://doi.org/10.1016/j.semnephrol.2009.03.002
|
[16]
|
Sterns, R.H., Riggs, J.E. and Schochet Jr., S.S. (1986) Osmotic Demyelination Syndrome Following Correction of Hyponatremia. The New England Journal of Medicine, 314, 1535-1542.
https://doi.org/10.1056/NEJM198606123142402
|
[17]
|
Gankam-Kengne, F., Couturier, B.S., Soupart, A., Brion, J.P. and Decaux, G. (2017) Osmotic Stress-Induced Defective Glial Proteostasis Contributes to Brain Demyelination af-ter Hyponatremia Treatment. Journal of the American Society of Nephrology, 28, 1802-1813. https://doi.org/10.1681/ASN.2016050509
|
[18]
|
Thomsen, R.W., Nicolaisen, S.K., Hasvold, P., et al. (2018) Ele-vated Potassium Levels in Patients with Chronic Kidney Disease: Occurrence, Risk Factors and Clinical Outcomes—A Danish Population-Based Cohort Study. Nephrology Dialysis Transplantation, 33, 1610. https://doi.org/10.1093/ndt/gfx312
|
[19]
|
Luo, J., Brunelli, S.M., Jensen, D.E. and Yang, A. (2016) Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function. Clinical Journal of the American Society of Nephrology, 11, 90-100.
https://doi.org/10.2215/CJN.01730215
|
[20]
|
Petramala, L., Savoriti, C., Zinnamosca, L., Marinelli, C., Sette-vendemmie, A., Calvieri, C., Catani, M. and Letizia, C. (2013) Primary Aldosteronism with Concurrent Primary Hy-perparathyroidism in a Patient with Arrhythmic Disorders. Internal Medicine, 52, 2071-2075. https://doi.org/10.2169/internalmedicine.52.8794
|
[21]
|
Ruljancic, N., Popovic-Grle, S., Rumenjak, V., Sokolic, B., Malic, A., Mihanovic, M., et al. (2007) COPD: Magnesium in the Plasma and Polymorphonuclear Cells of Patients dur-ing a Stable Phase. COPD, 4, 41-47.
https://doi.org/10.1080/15412550601169513
|
[22]
|
Siafakas, N.M. and Tzortzaki, E.G. (2002) Few Smokers De-velop COPD. Why? Respiratory Medicine, 96, 615-624.
https://doi.org/10.1053/rmed.2002.1318
|